Erratum: Formulation of a novel tianeptine sodium orodispersible film (AAPS PharmSciTech DOI: 10.1208/s12249-010-9464-2);Formulation of a novel tianeptine sodium orodispersible film

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1018-1025

  El Setouhy, Doaa Ahmed ^a   El Malak, Nevine Shawky Abd ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

bioavailability from orodispersible films and tablets; fast dissolving films; orodispersible films; solvent casting method; tianeptine sodium

Indexed keywords

HYDROXYETHYLCELLULOSE; HYDROXYMETHYLCELLULOSE; LYCOAT NG 73; MALTODEXTRIN; POLYMER; POLYVINYL ALCOHOL; POVIDONE; TIANEPTINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DISPERSIBLE TABLET; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHYSICOCHEMICAL MODEL; PRIORITY JOURNAL; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 78649905310     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9524-7     Document Type: Erratum

References (36)

1. F Cilurzo IE Cupone P Minghetti F Selmin L Montanari 2008 Fast dissolving films made of maltodextrins Eur J Pharm Biopharm 70 895 900 1:CAS:528:DC%2BD1cXhtlagsLzN 10.1016/j.ejpb.2008.06.032 18667164
2. Patel PB, Gupta GD. Fast dissolving drug delivery systems: an update. Pharminfo.net, 2006; 4.
3. S Keith 2006 Advances in psychotropic formulations Prog Neuropsychopharmacol Biol Psychiatry 30 996 1008 1:CAS:528:DC%2BD28XmtlGlsr4%3D 10.1016/j.pnpbp.2006.03.031 16678954 (Pubitemid 43949430)
4. S Gaisford A Verma M Saunders PG Royall 2009 Monitoring crystallization of drugs from fast-dissolving oral films with isothermal calorimetry Int J Pharm 380 105 11 1:CAS:528:DC%2BD1MXhtV2hsLfL 10.1016/j.ijpharm.2009.07.006 19596058
5. Shimoda H, Taniguchi K, Nishimura M, Matsuura K, Tsukioka T, Yamashita H, et al. Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Eur J Pharm Biopharm. 2009, doi: 10.1016/j.ejpb.2009.08.010.
6. RC Mashru VB Sutariya MG Sankalia PP Parikh 2005 Development and evaluation of fast-dissolving film of salbutamol sulphate Drug Dev Ind Pharm 31 25 34 1:CAS:528:DC%2BD2MXhtlaqtL4%3D 15704855
7. A Dinge M Nagarsenker 2008 Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity AAPS PharmSciTech 9 349 56 1:CAS:528:DC%2BC3cXnslGjtr8%3D 10.1208/s12249-008-9047-7 18431674
8. MG Ahmed RN Charyulu NM Harish P Prabhu 2009 Formulation and in-vitro evaluation of chitosan films containing tetracycline for the treatment of periodontitis Asian J Pharm 3 113 9 10.4103/0973-8398.55048
9. Prissaux X, Josh A, Francois A, Lefevre P. Evaluation of a novel modified starch polymer in an easy to formulate thin film drug delivery system and comparison with some marketed formulations. AAPS 2007. Available at: ( www.roquette-pharm.com ). Accessed July 2009.
10. R Defrance C Marey A Kamoun 1988 Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials Clin Neuropharmacol 11 S74 82 2902922
11. A Khedr 2007 High-performance liquid chromatographic stability indicating assay method of tianeptine sodium with simultaneous fluorescence and UV detection J Chromatogr Sci 45 305 10 1:CAS:528:DC%2BD2sXntFyntrY%3D 17626716
12. TI Uzbay H Kayir M Ceyhan 2007 Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors Neuropsychopharmacology 32 412 6 1:CAS:528:DC%2BD2sXltlSjsQ%3D%3D 10.1038/sj.npp.1301143 16823386 (Pubitemid 46106947)
13. PS Muniz AE Nardi 2004 Refractory pain-depression syndrome treated with tianeptine: a case report Aust N Z J Psychiatry 38 176 82 10.1111/j.1440-1614. 2004.01328.x 14961940 (Pubitemid 38488932)
14. TI Uzbay 2008 Tianeptine: potential influences on neuroplasticity and novel pharmacological effects Prog Neuropsychopharmacol Biol Psychiatry 32 915 24 1:CAS:528:DC%2BD1cXls1yrsbs%3D 10.1016/j.pnpbp.2007.08.007 17826881 (Pubitemid 351609223)
15. AP Gorle SG Gattani 2009 Design and evaluation of polymeric ocular drug delivery system Chem Pharm Bull 57 914 9 1:CAS:528:DC%2BD1MXhtlOqtb%2FP 10.1248/cpb.57.914 19721251
16. HO Ammar M Ghorab SA El-Nahhas R Kamel 2009 Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation AAPS PharmSciTech 10 7 20 10.1208/s12249-008-9167-0 1:CAS:528: DC%2BC3cXotV2mt7g%3D 10.1208/s12249-008-9167-0 19132537
17. MM Rawas-Qalaji FE Simons KJ Simons 2006 Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics AAPS PharmSciTech 7 E1 7 10.1208/pt070241
18. JL Cohen BB Hubert LJ Leeson CT Rhodes JR Robinson TJ Roseman, et al. 1990 The development of USP dissolution and drug release standards Pharm Res 7 983 7 1:STN:280:DyaK3M7isF2ktw%3D%3D 10.1023/A:1015922629207 2281043
19. JO Kim JY Choi JK Park JH Kim SG Jin SW Chang 2008 Development of clindamycin-loaded wound dressing with polyvinyl alcohol and sodium alginate Biol Pharm Bull 31 2277 82 1:CAS:528:DC%2BD1MXit1Kmt70%3D 10.1248/bpb.31.2277 19043213
20. S Miyazaki A Nakayama M Oda M Takada D Attwood 1995 Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate Int J Pharm 118 257 63 1:CAS:528:DyaK2MXks1Kns7Y%3D 10.1016/0378-5173(94)00396-M
21. J Mannila T Järvinen K Järvinen M Tarvainen P Jarho 2005 Effects of RM-beta-CD on sublingual bioavailability of delta9- tetrahydrocannabinol in rabbits Eur J Pharm Sci 26 71 7 1:CAS:528: DC%2BD2MXntVGjs7w%3D 10.1016/j.ejps.2005.04.020 15955678 (Pubitemid 41097263)
22. J Mannila T Järvinen K Järvinen J Tervonen P Jarho 2006 Sublingual administration of delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of delta9-tetrahydrocannabinol in rabbits Life Sci 78 1911 4 1:CAS:528:DC%2BD28XitVGgsrw%3D 10.1016/j.lfs.2005.08.025 16266727
23. Moffat A, Osselton MD, Widdop B, Galichet LY. Clarke's Analysis of Drugs and Poisons, electronic version. 3rd ed. London: Pharmaceutical Press; 2004.
24. JM Gaulier P Marquet E Lacassie R Desroches G Lachatre 2000 High-performance liquid chromatographic determination of tianeptine in plasma applied to pharmacokinetic studies J Chromatogr 748 407 14 1:CAS:528: DC%2BD3cXotFKjtLs%3D 10.1016/S0378-4347(00)00368-6
25. British Pharmacopoeia III, Her Majesty's Stationery Office Ltd., London, 2003. pp. 2598-2599
26. P Arora B Mukherjee 2002 Design, development, physicochemical, and in-vitro and in-vivo evaluation of transdermal patches containing diclofenac diethylammonium salt J Pharm Sci 91 2076 89 1:CAS:528:DC%2BD38XmsVSgsLg%3D 10.1002/jps.10200 12210054 (Pubitemid 36254943)
27. NA Nafee FA Ismail NA Boraie LM Mortada 2003 Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing Int J Pharm 264 1 14 1:CAS:528:DC%2BD3sXmvF2ks7c%3D 10.1016/S0378-5173(03)00371-5 12972331 (Pubitemid 37297629)
28. L Chen SH Imam SH Gordon RV Greene 1997 Starch-polyvinyl alcohol crosslinked film performance and biodegradation J Environ Polym Degrad 5 111 7 1:CAS:528:DyaK2sXjsFOkurk%3D
29. MG Katz T Wydeven 1982 Selective permeability of PVA membranes. II. Heat-treated membranes J Appl Polym Sci 27 79 87 1:CAS:528:DyaL38XmvFyhtw%3D%3D 10.1002/app.1982.070270109 (Pubitemid 12473481)
30. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services Food and Drug Administration. 2001.
31. Chakravorty S, Hariharan V. Mouth dissolvable and meltable, and water dispersible delivery formulation USPC Class: 514242 IPC8 Class: AA61K3153FI.
32. RW Korsmeyer R Gurny E Doelker P Buri NA Peppas 1983 Mechanisms of solute release from porous hydrophilic polymers Int J Pharm 15 25 35 1:CAS:528:DyaL3sXksVens7Y%3D 10.1016/0378-5173(83)90064-9 (Pubitemid 13092121)
33. I Diaz del Consuelo F Falson RH Guy Y Jacques 2007 Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl J Control Release 122 135 40 1:CAS:528:DC%2BD2sXhtVSktbjJ 10.1016/j.jconrel.2007.05.017 17688966 (Pubitemid 47361402)
34. Daniel JZ, Michael DR, Albert H. Edible film formulations containing maltodextrin, 2004; US patent: 6,740,332.
35. Prissaux X, Josh A, Dussautois C, Le Bihan G, Lefevre P. Functional advantages of a novel modified starch over HPMC in aqueous film coating of tablets. AAPS 2006. Available at: ( www.roquette-pharm.com ). Accessed July 2009.
36. J Zou B Di CY Wu Q Hu JH Li Y Zhu, et al. 2008 Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations: a randomized-sequence, open-label, two-period crossover study in healthy Chinese adult male volunteers Clin Ther 30 654 60 1:CAS:528:DC%2BD1cXhtVWltLnF 10.1016/j.clinthera.2008.04.003 18498914 (Pubitemid 351680490)